Cell name:
OCI-LY7
Other names for the model:
OCI-Ly7、OCI-LY-7 、OCI-Ly-7、Oci-Ly-7、OCI-Ly 7、OCI-Ly07、OCILY7、Ly7、LY7
Cell information:
OCI-LY7 cells are derived from human diffuse large B lymphoma and are often used for screening BCL-6 inhibitors. Click to viewMore information.
Model information:
Subcutaneous inoculation, the mouse strain is NOD/SCID, and matrix needs to be added during inoculation. Approximately 14 days after vaccination, the group can be divided into groups, and the administration time after grouping is approximately 20 days.Email: BD@truwaybio.com
Business: +86 185-0139-0702
Technology: +86 137-7300-5709
Website Usage Help: +86 188-6238-7270
Landline: +86 0512-80601059
Email: BD@truwaybio.com
Business: +86 185-0139-0702
Technology: +86 137-7300-5709
Website Usage Help: +86 188-6238-7270
Landline: +86 0512-80601059